Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 4;16(3):e0248043. doi: 10.1371/journal.pone.0248043

Development of a novel index to characterise arterial dynamics using ultrasound imaging

Joel Ward 1,#, Xinghao Cheng 2,#, Yingyi Xiao 2, Pierfrancesco Lapolla 1, Anirudh Chandrashekar 1, Ashok Handa 1, Robin A Cleveland 2,‡, Regent Lee 1,‡,*
Editor: Athanasios Saratzis3
PMCID: PMC7932503  PMID: 33662025

Abstract

Abdominal aortic aneurysms (AAA) are associated with systemic inflammation and endothelial dysfunction. We previously reported flow mediated dilatation (FMD) of the brachial artery as a predictor of AAA growth. We hence hypothesised that other physical characteristics of the brachial artery correlate with AAA growth. Using a prospectively cohort of AAA patients, we devised a ‘brachial artery relaxation index’ (BARI) and examined its role as a biomarker for AAA growth. However, no correlation between BARI and future aneurysm growth was observed (p = 0.45). Therefore, our investigations did not substantiate the hypothesis that other physical characteristics of the brachial artery predicts AAA growth.

Introduction

Abdominal aortic aneurysms (AAA) are permanent and irreversible localised dilatations of the aorta involving all three layers of the vascular wall. The incidence of AAAs increase with age demonstrated through ultrasonography based screening studies diagnosing AAA in 1–2% of all 65−year-old men and in 0.5% of 70−year-old women [1, 2]. AAAs are usually asymptomatic so are most frequently detected either as part of screening programmes or incidentally on presentation to healthcare for an alternate pathology. AAAs have a tendency to expand, and as the size increases, so does the risk of rupture. When a AAA ruptures catastrophic intra-abdominal haemorrhage ensues which, if left untreated, results in mortality.

International guidelines recommend the A-P diameter threshold of 55mm for elective surgical repair in men, at which point the yearly risk of rupture outweighs the risks associated with an operation [3]. In addition to this, intervention is recommended for patients experiencing symptoms from their aneurysm, patients with saccular shaped aneurysms or those with aneurysms that expand quickly within one year [3]. Accordingly, patients with AAAs less than 55mm are typically kept under surveillance by regular ultrasound until the AAA expands above the threshold. Longitudinal studies have demonstrated that AAAs grow at different rates in different individuals and possess a variety of different physiological characteristics, the subtleties of which are not incorporated in current decision-making guidance [4, 5]. Although 70% of patients eventually meet the size threshold for an operation, they age and become more co-morbid during the observational period, raising the risks associated with intervention [4, 5]. Robust biomarkers of future AAA progression can improve clinical management by aiding identification of aneurysms which will progress to the necessitating intervention without requiring delay caused by a period of observation.

AAAs are associated with features of endothelial dysfunction throughout the cardiovascular system as well as a systemic inflammation response [6–8]. Endothelial function has been widely assessed using endothelial dependent function as a surrogate marker. One example of this includes flow mediated dilatation (FMD), which is a repeatable, non-invasive physiological assessment for the quantification of systemic endothelial function. FMD was shown to be inversely correlated with future AAA progression in humans; FMD deteriorates during the natural history of AAA, and is improved by surgery in a fashion predictable with modest accuracy [9].

We sought to improve the predictive power by incorporating further biomechanical data extractable from the ultrasound data loops already recorded for FMD to find another novel biomarker during the natural history of individuals with AAAs. We hypothesise that intrinsic physical viscoelastic characteristics of the brachial artery wall correlate with AAA growth.

Material and methods

Details regarding the OxAAA study cohort and recruitment process have been published [9]. The Oxford Abdominal Aortic Aneurysm (OxAAA) study is designed to investigate longitudinally the natural history of AAAs. The study received full regulatory and ethics approval from the Oxford University and Oxford University Hospitals (OUH) National Health Service (NHS) Foundation Trust (Ethics Ref: 13/SC/0250). Every participant provided written consent. Participants were recruited at the John Radcliffe Hospital, which is part of the OUH NHS Foundation Trust.

The AAA size was defined by the maximal anteroposterior diameter (outer-to-outer). We defined further subgroups according to the AP diameter (APD) into small (30-39mm), moderate (40-55mm), and large (>55mm) AAAs. The annual growth rate of AAA during surveillance was calculated by: (ΔAPD/APD at baseline) / (number-of-days-lapsed/365days).

The clinical encounter can be a stressful experience for the study participants. To minimise the effect of this, we synchronised the research assessment with their regular NHS appointments for AAA surveillance scans, during daytime hours. This minimised the inconvenience to the participants. Participants were required to fast for 6 hours before the study (except their regular medications) and to refrain from caffeinated beverages and cigarette smoking for 24 hours prior to their visits. To minimise stress, the study was performed in a dimly lit, quiet room, with the patient in the supine position separate to their clinical appointment. This was described in our original publication detailing the methods of FMD measurement [9]. B mode ultrasound imaging of the brachial artery was then performed using the CX50 ultrasound machine (Phillips, Amsterdam, Netherlands) with a L12-3 probe which was mounted using a bespoke holder (Fig 1) to record brachial artery motion during four cardiac cycles. All data were anonymised before use in the work reported in this article.

Fig 1. Set up to record brachial artery ultrasound video loop.

Fig 1

Image analysis

Ultrasound recordings were saved in DICOM format and imported into MATLAB® (The MathWorks Inc. Natick, Massachusetts, USA) for analysis. Brachial artery wall positions were detected using a modified version of a level set evolution (LSE) approach traditionally used in MRI information processing [10]. This LSE method exploits the difference in pixel intensity in the grey scale ultrasound to locate the contours. A user-defined rectangle was manually placed within the lumen position in the first frame of each ultrasound recording (Fig 2, panel A). The algorithm then iterated outwards towards the arterial wall detecting differences based on the brightness intensity contrast. The algorithm was designed to find the contours of the vessel outside the initial user-defined rectangle. Care was taken such that the rectangular region of interest is not close to lumen edges to prevent overlap with the arterial wall during cardiac cycles.

Fig 2. Image of a frame extracted from the ultrasound video of a brachial artery.

Fig 2

The dotted rectangle is a user specified initialisation for the level set algorithm. (A) The green lines show the final estimate of the anterior and posterior vessel wall from the level set algorithm (B) Additional slice thickness artefact densities present in vessel lumen.

At each horizontal location in the image (x), the top of the lumen yt(x) and the bottom of the lumen yb(x) were determined. This was repeated for each image in the cine loop which normally contained four cardiac cycles. Fig 3 shows an example surface plot of yB(xH)ad yt(x, t) where four cycles can be seen and the response is reasonably uniform along the length of the artery that was imaged. The diameter D as a function of x was determined by:

D=|yb-yt| (1)

Fig 3. Response of brachial vessel wall in time and space over four cardiac cycles.

Fig 3

The contour acquisition is conducted by the segmentation algorithm throughout the period of the ultrasound video clip. The expansion of the vessel during systole can be seen at about 0.5 s, 1.5 s, 3.0 s and 4.0 s. Cyan contours represent the posterior vessel wall. Magenta contours represent the anterior vessel wall.

At each location x, the diameter D(x,t) was manually using the peaks and troughs so that systole and diastole could be identified, see Fig 4. The diameter of the vessel dilatation during systole was fit to a single exponential rise time.

∪Dd(t)=Ad-Bd×e-(t-CdTd) (2)

Where A and B, C and T are parameters to be fit. The relaxation during diastole was not well modelled by one time constant and therefore two time constants were employed to fit the diameter.

Fig 4. Diameter variation as a function of time at a specific cross section showing four cardiac cycles.

Fig 4

The crosses show the measured results and the lines are the fitting curves for dilatation (red) and relaxation (blue). The diameter of the last cardiac cycle in the figure was not well fitted by a two time-scale decay and these data sets were excluded and not included in further analysis.

Dr(t)=Ar+BR1ⅇ-(t-CrTR1)+BR2ⅇ-(t-CrTR2) (3)

Here the relaxation time constants will be referred to as fast, TR1 and slow, TR2. The motivation for using exponential modes is that tissue is commonly modelled using as a series of springs and dashpots, the so-called Zener model which has exponential solutions [11]. For systole the response is a convolution of the driving pressure and vessel wall dynamics and so extracting wall properties is challenging. However, for diastole the temporal dynamics should be dominated by the properties of the wall which are captured by TR1 and TR2. The slow fall occurs under minimal arterial pressure and so is most sensitive to wall properties.

Assuming the incoming pulses are square waves with very short on duration, the tissue response is formed by three compartments in terms of the diameter: (i) steep rise (a convolution of the driving waveform and the tissue response), (ii) steep fall, (iii) slow fall before the next pulse comes. The steep rise and fall are caused by the forcing input, thus the composition of these two parts are mainly the input forcing term.

The best fit curves and time constants were constructed using the fminsearch function in MATLAB® (The MathWorks, Inc.), based on the Nelder-Mead simplex algorithm [12], in which convergence in low dimension has been verified in [13]. The cost function that is used in the minimalisation is the summation of standard L2-Norm, between the data and either Eqs 2 or 3.

The initialisation of parameters for fminsearch was as follows: The vertical (A_d, A_r) and horizontal (C_d, C_r) shifts’ were set to the mean of the values’ range within a fitting section to start with (diameter and time, respectively). The exponentials’ magnitudes (B_d, B_r and D_r) were the size of one pixel. TR2 was set to the time period of the relaxation section (ie diastole) and TR1 = TR2 / 10.

The brachial artery relaxation index (BARI) is defined by the mean relaxation constant of the exponential curves. The pilot data indicated that TR2 was more likely to be a parameter differentiating aneurysm growth rate. Therefore, resulting analysis was focused on the diameter relaxation sections and the corresponding fittings.

Results

Algorithm defined lumen wall positions were faithful to true brachial artery wall position in good quality ultrasound recordings (Fig 2, panel A) with an accuracy on the order of an image voxel (21 μm). The algorithm was unable to reliably locate wall position for 12 patients and these were excluded from further analysis. The most common issue encountered was the presence of a slice artefact in the lumen (Fig 2, panel B).

Matlab was used to create a 3D plot (Fig 3) displaying vessel wall movement, as a function of position along vessel and time through recording. As the segmentation algorithm decides how complicated the contour’s shape must be to represent it at certain accuracy, the number of points representing each contour is generally different for a pair of top and bottom contours. In some cases, the segmentation returns “S” and “Z” shaped contours, means that for a single (x) position entry, there may be more than one contour (y) position values. The algorithm was written to include feasible manipulations to mitigate the above two issues in Eq 1. Before calculating the diameter, each contour is checked for whether there is more than one entry on a single horizontal position. If there is, the average is taken to be the value used in Eq 1.

For every location along the artery the diameter change was captured during cardiac cycles and curves fitted for dilatation and relaxation (Fig 4). The generated time constants were hypothesised to distinguish between fast and slow growing AAAs.

Comparison 1: Pilot study

A pilot study was performed on six patients with the slowest (S1-3) and fastest (F1-3) growing aneurysms in the OxAAA cohort. The time constant for diameter dilatation sections (TD) was not different between the two groups. BARI values are shown as bars in Fig 5 (green for slow growth AAA patients, red for fast growth AAA patients). The data suggests that BARI can be used to separate fast from slow based on a BARI threshold of 1.5s.

Fig 5. Comparison of BARI between representative slow (S1, S2 and S3) growth and fast growth (F1, F2 and F3).

Fig 5

Relaxation time constant values are marked in crosses for each patient. The bars represent the BARI values derived from the data crosses for each patient (Green: slow growth patients. Red: fast growth patients). Dashed line at BARI = 1.5 suggests a threshold value to separate patient’s growth type.

This positive result demonstrating separation in a pilot study for the patients at the extreme spectrum of prospective AAA growth and the plausible theoretical basis for the biomarker led to further analysis being performed on rest of the OxAAA cohort, comparisons and patient flow as demonstrated in Fig 6 (demographic data in S1 Table).

Fig 6. Patient journey through OxAAA study.

Fig 6

Depicts data collection points and comparisons performed in this workflow.

Comparison 2: BARI between healthy volunteers and AAA patient cohort

16 healthy volunteers were age and gender matched to 16 patients from the aneurysmal cohort to assess whether BARI differed between patients with AAA (cohort) and without aneurysms (HV). There was no statistical difference observed between the two groups on unpaired t-test (HV median 0.93, HV interquartile range 0.65–0.99, Cohort median = 0.89, Cohort interquartile range = 0.82–1.03, P = 0.78).

Comparison 3: BARI between AAA of different sizes

126 participants with a diagnosis of AAA were recruited to the study. BARI could be derived in 114 participants, as the video image quality were not sufficient for this calculation in 12 of them. Comparison is made of three subgroups according to their aneurysm AP diameter: small (30-39mm), moderate (40-55mm), and large (>55mm). There was no significant difference observed between groups on Kruskal-Wallis (Small vs Large, P = 0.82, Small vs Medium, P = 0.99, Medium vs Large, P = 0.99). Spearman correlation of BARI against aneurysm size (mm) was not significant (p = 0.11), Fig 7.

Fig 7. BARI vs AAA size for 114 patients.

Fig 7

No correlation between aneurysm AP diameter (x-axis) and BARI (y-axis) P = 0.68.

Comparison 4: Correlation between BARI and future AAA growth

The growth rate of individual participants was calculated over 12 months in 87 participants with complete follow up during this period. Fig 8 shows measured BARI for each patient versus the AAA growth and no correlation was observed. Spearman correlation of BARI against % aneurysm growth per year was not significant (p = 0.45).

Fig 8. BARI vs AAA % growth per year for 87 patients.

Fig 8

Linear regression comparing aneurysm % AP diameter growth per year (x-axis) and BARI (y-axis) Slope 0.01 P = 0.46.

Discussion

This work was motivated by the desire to predict the growth and progression of AAAs. The existing surgical threshold based on a size criteria (>55mm) has intrinsic shortcomings, as aneurysm size is not an absolute predictor of the risk of rupture, and the rate of AAA progression varies greatly between individuals. Those with moderate size aneurysms have a small (1%) annual risk of rupture and the majority of patients (70%) with an initially small or moderate size AAA will progress and require surgery within 5 years [4, 5]. Improved biomarkers of future AAA progression would enable the stratification of patients who may benefit from surgery earlier than the existing size threshold and decrease the perioperative risk to those patients.

Our hypothesis was that US based measurements of the deformation of vessels walls could be used to extract mechanical properties of the vessels to provide information that could improve the ability to predict AAA progression. Preliminary data suggested that BARI, a measure of a relaxation time scale had the most promise. Unfortunately, there was no significant difference in BARI between aneurysmal patients and healthy volunteers, nor did it vary according to aneurysm size. It offered no predictive value for aneurysm growth at 12 months. Although BARI did not appear to improve the ability to predict growth in AAAs, the processing approach described here to extract mechanical properties from ultrasound image analysis may have alternate applications in other pathologies or the research setting.

Investigating physiological characteristics of vasculature using imaging is an important part of developing our understanding of cardiovascular and aneurysmal disease. Better definition of the biophysical characteristics of vasculature in healthy and pathological states is important to help underpin future research. Ultrasound is an ideal imaging modality to extract biomechanical properties as it is non-invasive, functional, widely accessible and without exposure to ionising radiation.

As we did not observe correlation between BARI and future AAA growth, we did not proceed to examine potential confounding effects of the other demographic variables. As a post hoc analysis, we examined the association between BARI and the demographic variables as summarised in S1 Table. It is interesting that BARI had significant correlation with some demographic variables (gender, history of smoking, prior diagnosis of hypertension or diabetes). We further observed a significant correlation between BARI and aneurysm growth in female, however the sample size of females was too small. That BARI does not correlate with mean arterial pressure or HbA1C indicate that these patients have received appropriate medical therapy for their prior diagnosis of hypertension and diabetes.

We had hypothesised BARI would help the predictive index for aneurysm growth, in addition to existing biomarkers such as FMD, AAA diameter and circulating plasma proteins [9, 14]. Our data did not support this. It would have been preferable to perform the same analysis using ultrasound imaging of the AAA itself. However, as the AAA is an organ structure deep inside the abdominal cavity, ultrasound imaging of the AAA is only feasible using a low frequency probe (typically at 3MHz) to achieve the depth penetration. The images acquired using this probe were found to be too low in resolution for the analysis described here to extract pulsatile expansion of the AAA. Nevertheless, BARI is a novel image analysis technique which underscores the importance of active pursuit of imaging biomarkers, across various modalities to help inform clinical decision making for AAAs.

Conclusion

We developed a novel method to characterise the viscoelastic properties of brachial artery (BARI). Although BARI did not correlate to future AAA growth as hypothesised, our workflow demonstrates a pipeline of interdisciplinary research which can be applied to other areas of research.

Supporting information

S1 Table. Summary of participant demographics and their association with BARI.

Participant baseline demographics were collected at the time of enrollment to the study. Characteristics that follow a Gaussian/Normal Distribution are presented using mean ± SD, and cohort differences are compared using a student t-test. For variables that don’t follow a Gaussian distribution, median and inter-quartile range (IQR) are presented and cohort differences are compared using a Mann-Whitney test. BMI: body mass index. CAD: coronary artery disease, PAD: peripheral arterial occlusive disease, ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.

(PDF)

S1 Data. Spreadsheet of anonymised dataset as analysed.

Gender: 1—Male, 0 –Female BMI: body mass index, MAP: mean arterial pressure, HTN: hypertension ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.

(XLSX)

Acknowledgments

Contributors to the OxAAA Study include: Amy Jones, Felicity Woodgate, Nicholas Killough, Kirthi Bellamkonda, Sowmya Mangipudi, Members of the Oxford Regional Vascular Services and the Jackie Walton Vascular Studies Unit.

Data Availability

All relevant data are within the paper and its Supporting information files. The raw research data remains the property University of Oxford and can be made available to other researchers based with material transfer agreement in place. This can be arranged through the Oxford University research services research.services@admin.ox.ac.uk).

Funding Statement

The Oxford Abdominal Aortic Aneurysm Study was supported by the following: University of Oxford, Medical Sciences Division Medical Research Fund (MRF/HT2016/2191); University of Oxford, Nuffield Department of Surgical Sciences; John Fell Oxford University Press Research Fund (142/075); National Institute of Health Research (NIHR) Oxford Biomedical Research Centre; Regent Lee was supported by a Academy of Medical Science Starter Grant, UK (SGL013/1015). Pierfrancesco Lapolla was supported by an EU Erasmus+ traineeship studentship. Anirudh Chandrashekar is a Clarendon Keble Scholar, University of Oxford.

References

  • 1.Grøndal N, Søgaard R, Lindholt JS. Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial). British Journal of Surgery. 2015;102(8):902–6. [DOI] [PubMed] [Google Scholar]
  • 2.Oliver‐Williams C, Sweeting M, Turton G, Parkin D, Cooper D, Rodd C, et al. Lessons learned about prevalence and growth rates of abdominal aortic aneurysms from a 25‐year ultrasound population screening programme. British Journal of Surgery. 2018;105(1):68–74. 10.1002/bjs.10715 [DOI] [PubMed] [Google Scholar]
  • 3.Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA, Mansour MA, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.e2. Epub 2017/12/23. 10.1016/j.jvs.2017.10.044 . [DOI] [PubMed] [Google Scholar]
  • 4.Moxon JV, Parr A, Emeto TI, Walker P, Norman PE, Golledge J. Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Current problems in cardiology. 2010;35(10):512–48. 10.1016/j.cpcardiol.2010.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rutherford RB, editor Open versus endovascular stent graft repair for abdominal aortic aneurysms: an historical view. Seminars in vascular surgery; 2012: Elsevier. [DOI] [PubMed]
  • 6.Knipp BS, Peterson DA, Rajagopalan S, Kehrer C, Ford JW, D’Alecy LG, et al. Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. Journal of vascular surgery. 2002;35(2):363–7. 10.1067/mva.2002.121069 [DOI] [PubMed] [Google Scholar]
  • 7.Medina F, de Haro J, Florez A, Acin F. Relationship between endothelial dependent vasodilation and size of abdominal aortic aneurysms. Annals of vascular surgery. 2010;24(6):752–7. 10.1016/j.avsg.2009.11.011 [DOI] [PubMed] [Google Scholar]
  • 8.Sung S-H, Wu T-C, Chen J-S, Chen Y-H, Huang P-H, Lin S-J, et al. Reduced number and impaired function of circulating endothelial progenitor cells in patients with abdominal aortic aneurysm. International journal of cardiology. 2013;168(2):1070–7. 10.1016/j.ijcard.2012.11.002 [DOI] [PubMed] [Google Scholar]
  • 9.Lee R, Bellamkonda K, Jones A, Killough N, Woodgate F, Williams M, et al. Flow mediated dilatation and progression of abdominal aortic aneurysms. European Journal of Vascular and Endovascular Surgery. 2017;53(6):820–9. 10.1016/j.ejvs.2017.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Li C, Huang R, Ding Z, Gatenby JC, Metaxas DN, Gore JC. A level set method for image segmentation in the presence of intensity inhomogeneities with application to MRI. IEEE Trans Image Process. 2011;20(7):2007–16. Epub 2011/04/27. 10.1109/TIP.2011.2146190 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Balocco S, Basset O, Courbebaisse G, Boni E, Frangi AF, Tortoli P, et al. Estimation of the viscoelastic properties of vessel walls using a computational model and Doppler ultrasound. Physics in Medicine & Biology. 2010;55(12):3557. 10.1088/0031-9155/55/12/019 [DOI] [PubMed] [Google Scholar]
  • 12.Lagarias JC, Reeds JA, Wright MH, Wright PE. Convergence Properties of the Nelder—Mead Simplex Method in Low Dimensions. SIAM J Optim. 2006;9(1):112–47. 10.1137/S1052623496303470 [DOI] [Google Scholar]
  • 13.Klein K, Neira J. Nelder-Mead Simplex Optimization Routine for Large-Scale Problems: A Distributed Memory Implementation. J Comput Econ. 2014;43:447–61. [Google Scholar]
  • 14.Lee R, Charles PD, Lapolla P, Cassimjee I, Huang H, Kessler B, et al. Integrated physiological and biochemical assessments for the prediction of growth of abdominal aortic aneurysms in humans. Annals of surgery. 2019;270(1):e1–e3. 10.1097/SLA.0000000000003154 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Athanasios Saratzis

26 Jan 2021

PONE-D-20-40123

Development of a Novel Index to Characterise Arterial Dynamics Using Ultrasound Imaging

PLOS ONE

Dear Dr. Lee,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Athanasios Saratzis

Academic Editor

PLOS ONE

Additional Editor Comments:

Thank you very much for submitting this interesting Article to PLOS ONE.

Some major comments / issues were raised by the Reviewers, who are both world-class experts in diagnosis and management of aneurysmal disease. We would be most grateful if you could please address all points raised, but most importantly explain why this specific artery was chosen (radial). Please address the comment(s) raised about other arterial segments such as the popliteal artery (especially since this is the most common site of aneurysmal disease).

The manuscript will have to be re-evaluated by the Reviewers given their feedback.

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.) We note that you have a patent relating to material pertinent to this article. Please provide an amended statement of Competing Interests to declare this patent (with details including name and number), along with any other relevant declarations relating to employment, consultancy, patents, products in development or modified products etc. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

This information should be included in your cover letter; we will change the online submission form on your behalf.

3.) We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4.) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5.) We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms (https://doi.org/10.1016/j.ejvs.2017.03.001).

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: An interesting paper. I agree that other biomarkers would be useful to predict AAA growth and that size is too simplistic.

Can the authors comment on the following-

1. Why choose the brachial artery? Ease of access is obvious but there is some data to suggest that AAA is a systemic dilating disease and the popliteal artery (with its association with AAA) was chosen

2. Have you allowed for confounding factors? Many of these patients will also have other risk factors (high BP, smoking etc) - does this affect your results? Do drugs affect the relaxation index? The patients were all studied during a clinical visit that can be stressful? Did you make allowances for this?

3. A null hypothesis and power calculation would help

Reviewer #2: Thank you for your well-written paper. I have the following comments:

1. Page 3, Lines 22: The threshold of 55mm is not the only criterion. The expansion rate within one year as well as the shape of the aneurysm sac are playing an important role as well.

2. Page 4, Line 39: Which is exactly the predictive power in percentage of the FMD in the brachial artery regarding the AAA identification?

3. Is the BARI and index that it has been evaluated in other studies?

4. The different number of patients presented in the results is very confusing. It would be meaningful to provide a flow diagram with all measurements performed and the respective cohorts of patients.

5. Page 10, Line 193: Please provide literature about these preliminary data.

6. Page 10, Line 195: How time-consuming is to measure the BARI and how can we simplify it in order to investigate further cardiovascular pathologies

7. Why did you select brachial artery and not radial artery? Is the size that makes the difference? Why not CFA or carotid artery or even better popliteal artery which is the second more frequent artery with aneurysmatic degeneration?

8. Do you think that further improvement of US device could provide more data regarding direct measurement of BARI in the abdominal aorta?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Robert Sayers

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 4;16(3):e0248043. doi: 10.1371/journal.pone.0248043.r002

Author response to Decision Letter 0


12 Feb 2021

Please refer to the attached Response to Reviewer document for detailed response to reviewer feedback including new figures and references.

Attachment

Submitted filename: Response to Reviewers PLOS One.docx

Decision Letter 1

Athanasios Saratzis

19 Feb 2021

Development of a Novel Index to Characterise Arterial Dynamics Using Ultrasound Imaging

PONE-D-20-40123R1

Dear Dr. Lee,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Athanasios Saratzis

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Athanasios Saratzis

23 Feb 2021

PONE-D-20-40123R1

Development of a Novel Index to Characterise Arterial Dynamics Using Ultrasound Imaging

Dear Dr. Lee:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Athanasios Saratzis

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Summary of participant demographics and their association with BARI.

    Participant baseline demographics were collected at the time of enrollment to the study. Characteristics that follow a Gaussian/Normal Distribution are presented using mean ± SD, and cohort differences are compared using a student t-test. For variables that don’t follow a Gaussian distribution, median and inter-quartile range (IQR) are presented and cohort differences are compared using a Mann-Whitney test. BMI: body mass index. CAD: coronary artery disease, PAD: peripheral arterial occlusive disease, ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.

    (PDF)

    S1 Data. Spreadsheet of anonymised dataset as analysed.

    Gender: 1—Male, 0 –Female BMI: body mass index, MAP: mean arterial pressure, HTN: hypertension ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers PLOS One.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files. The raw research data remains the property University of Oxford and can be made available to other researchers based with material transfer agreement in place. This can be arranged through the Oxford University research services research.services@admin.ox.ac.uk).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES